| Description | Remtolumab (ABT-122), a dual-variable domain immunoglobulin, neutralizes tumor necrosis factor α (TNFα) and IL-17A, demonstrating dual inhibition of both. This compound is utilized in rheumatoid arthritis (RA) research [1] [2]. |
| molecular weight | N/A |
| CAS | 1791410-27-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |